Arginine Replacement Therapy in COVID-19
NCT05855330
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
21
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
Arginine Hydrochloride
Sponsor
Emory University